Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$161.01 - $317.85 $729,053 - $1.44 Million
4,528 New
4,528 $1.43 Million
Q2 2023

Aug 14, 2023

BUY
$176.32 - $240.22 $656,792 - $894,819
3,725 Added 269.54%
5,107 $1.11 Million
Q1 2023

May 12, 2023

SELL
$161.33 - $204.36 $512,706 - $649,456
-3,178 Reduced 69.69%
1,382 $251,000
Q4 2022

Feb 13, 2023

BUY
$191.53 - $236.82 $170,461 - $210,769
890 Added 24.25%
4,560 $896,000
Q3 2022

Nov 14, 2022

BUY
$123.79 - $277.42 $454,309 - $1.02 Million
3,670 New
3,670 $825,000
Q1 2022

May 16, 2022

SELL
$98.9 - $132.37 $348,029 - $465,810
-3,519 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$110.64 - $159.4 $389,342 - $560,928
3,519 New
3,519 $461,000

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.